The drug industry's voice for manufacturing excellence
Production
Development
Information Technology
Compliance
Quality & Risk
Sections
Production
Development
Information Technology
Compliance
Quality & Risk
Facilities
Sectors
Special
Webinars
Podcasts
E-Handbooks
Industry News
Magazine Archives
Contact
Newsletter Subscription
Contact Us
Advertise
Follow us on
https://www.facebook.com/pages/Pharmaceutical-Manufacturing/140261116014887
http://www.linkedin.com/groups?gid=1813799
http://twitter.com/PharmaMfg
cGMPs
Diabetes Drug From Lilly, Amylin Under Scrutiny
FDA asks for more detail on labeling of Bydureon, pharmaceutical firms' shares show little impact.
March 15, 2010
Add Us On Google
Sign up for our eNewsletters
Get the latest news and updates
Sign Up
Related
Charles River reports lower Q4 2025 revenue in struggling CDMO business
Fujifilm doubles quality control footprint at Danish commercial-scale manufacturing site
Sponsored
2026 Manufacturing Pharma Trends for Life Sciences
Sponsored
2026 AI Trends in Life Sciences
Trending
Eli Lilly navigates the uncharted waters of standing up multiple mega sites
Lonza’s large-scale mammalian site in Visp, Switzerland continues ramp-up process
US biomanufacturing investment gains momentum as output rises: report
Sponsored Picks
Sponsored
The Battle in Your Pipes: Gravity vs Air Velocity in Condensate Mgmt
Sponsored
An Advanced Way to Install a Compressed Air System
Sponsored
Condensate Management in Your Compressed Air System
Load More Content